普莱柯：2025年净利润预增89.64% - 110.11%

Core Viewpoint - The company expects a significant increase in net profit for the year 2025, driven by new product launches and effective marketing strategies [1] Financial Performance - The projected net profit attributable to the parent company is estimated to be between 176 million to 195 million yuan, representing a year-on-year increase of 89.64% to 110.11% [1] - The projected non-recurring net profit is estimated to be between 137 million to 153 million yuan, reflecting a year-on-year increase of 70.19% to 90.07% [1] - In the same period last year, the company's net profit attributable to the parent was 92.81 million yuan, and the non-recurring net profit was 80.50 million yuan [1] Business Drivers - The performance increase is primarily attributed to the launch of new products, particularly the avian adenovirus series vaccines, and the positive development in the pet segment [1] - The company is focusing on marketing transformation and cost reduction to enhance efficiency [1]